Neoadjuvant Chemotherapy for Breast Cancer

Clive, IA US
August 21, 2019

Target Audience

Nursing, Physicians, Radiologists, Pathologists, Lymphedema Therapists, residents, medical students, and other interested health care professionals who are involved in the management of patients with breast cancer and breast health issues.

Purpose

Provide current education in the diagnosis and overall treatment of breast cancer as related to breast imaging, diagnostic procedures, surgery, chemotherapy, radiation therapy, reconstruction, and lymphedema therapy.

Learning Objectives

  • Discuss various medical/surgical/radiological diagnoses and treatment strategies utilized in breast cancer and breast health issues.
  • Identify the importance of a team approach to the diagnosis, overall treatment plan, and follow up care to breast cancer and breast health issues. 
  • Discuss current issues related to breast health and breast cancer.

Moderator

Susan Beck, DO, 
Medical Director, Katzmann Breast Center, Mercy Medical Center

Biography

Relevant to the content of this CME activity, Dr. Beck indicated she has no financial relationships with commercial interest companies to disclose.

Course summary
Available credit: 
  • 1.00 AOA Category 1­A
Course opens: 
08/21/2019
Course expires: 
08/21/2019
Event starts: 
08/21/2019 - 7:00am CDT
Event ends: 
08/21/2019 - 8:00am CDT
Cost:
$0.00
Rating: 
0
Mercy Comfort Health Center for Women
1601 NW 114th Street
Clive, IA 50325
United States

Continuing Education Credit

  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

Educational Grants

No commercial interest company provided financial support for this continuing education activity.

Disclaimer

Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

Available Credit

  • 1.00 AOA Category 1­A

Price

Cost:
$0.00
Please login or Create an Account to take this course.